Mr. STEVE GARG Reference: Dr.

PRABHAT ARYA VID: 230054000296258

C8/103 SRS RESIDANCY SECTOR 88 Sample Collected At: Registered On:
FARIDABAD,FARIDABAD, FARIDABAD Maa HealthCare 03/04/2023 09:28 AM
Tel No : 8700860083 SHOP NO 5960, HUDA MARKET,PART- Collected On:
PIN No: 121002 1,SECTOR 16A, FARIDABAD
HARYANA,121002 03/04/2023 9:30AM
PID NO: P542300316622 Sample Processed At: Metropolis Reported On:
Age: 25.0 Year(s) Sex: Male Healthcare Ltd E-21, B1 Mohan Co-op 03/04/2023 02:43 PM
Ind Estate New Delhi-110044

Haemogram

Investigation Observed Value Unit Biological Reference Interval

Erythrocytes
Erythrocyte (RBC) Count 4.49 mill/cu.mm 4.7-6.0
Haemoglobin (Hb) 13.9 g/dL 13.5-18
HCT(Hematocrit) 41.7 % 42-52
MCV (Mean Corpuscular Volume) 92.9 fL 78-100
MCH (Mean Corpuscular Hb) 30.9 pg 27-31
MCHC (Mean Corpuscular Hb Concn.) 33.3 g/dL 32-36
RDW (Red Cell Distribution Width) 15.4 CV% 11.5-14.0
Leucocytes
Total Leucocytes (WBC) count 6600 cells/cu.mm 4300-10300
Absolute Neutrophils Count 5676 /c.mm 2000-7000
Absolute Lymphocyte Count 726 /c.mm 1000-3000
Absolute Monocyte Count 132 /c.mm 200-1000
Absolute Eosinophils Count 66 /c.mm 20-500
Absolute Basophils Count 0 /c.mm 20-100
Neutrophils 86 % 40-80
Lymphocytes 11 % 20-40
Monocytes 2 % 2.0-10
Eosinophils 1 % 1-6
Basophils 0 % 0-2
Platelets
Platelet count 229 10^3 / µl 150-450
MPV (Mean Platelet Volume) 8.3 fL 6-9.5
PCT ( Platelet Haematocrit) 0.19 % 0.2-0.5
PDW (Platelet Distribution Width) 17.1 % 9-17
EDTA Whole Blood : Test is done on Automated Five Part Cell Counter. Hemoglobin is measured by Spectrophotometry method.
WBC, RBC and Platelet Count are measured by Coulter Principle (Impedance Method). WBC Differential is done by VCS Method.
MCV and RDW are derived from RBC histogram. MPV and PDW are derived from Platelet histogram. Calculated Parameters are:
HCT, MCH, MCHC, PCT and Absolute WBC counts. All abnormal hemogram are reviewed and confirmed microscopically.
Differential count is based on approximately 10,000 cells.

Page 1 of 10 Dr. Chakshu Bansal

M.D (Pathology)
(DMC Reg. No. - 66994)
 Mr. STEVE GARG Reference: Dr.PRABHAT ARYA VID: 230054000296258
C8/103 SRS RESIDANCY SECTOR 88 Sample Collected At: Registered On:
FARIDABAD,FARIDABAD, FARIDABAD Maa HealthCare 03/04/2023 09:28 AM
Tel No : 8700860083 SHOP NO 5960, HUDA MARKET,PART- Collected On:
PIN No: 121002 1,SECTOR 16A, FARIDABAD
HARYANA,121002 03/04/2023 9:30AM
PID NO: P542300316622 Sample Processed At: Metropolis Reported On:
Age: 25.0 Year(s) Sex: Male Healthcare Ltd E-21, B1 Mohan Co-op 03/04/2023 02:43 PM
Ind Estate New Delhi-110044

HbA1c Glycated Haemoglobin

(EDTA Whole Blood)

Investigation Observed Value Unit Biological Reference Interval

HbA1C- Glycated Haemoglobin 5.6 % Non-diabetic: <= 5.6
(HPLC) Pre-diabetic: 5.7-6.4
Diabetic: >= 6.5
Estimated Average Glucose (eAG) 114.02 mg/dL
(Calculated)

Interpretation & Remark:

 

1. HbA1c is used for monitoring diabetic control. It reflects the estimated average glucose (eAG).
2. HbA1c has been endorsed by clinical groups & ADA (American Diabetes Association) guidelines 2022, for diagnosis of
diabetes using a cut-off point of 6.5%.
3. Trends in HbA1c are a better indicator of diabetic control than a solitary test.
4. Low glycated haemoglobin(below 4%) in a non-diabetic individual are often associated with systemic inflammatory diseases,
chronic anaemia(especially severe iron deficiency & haemolytic), chronic renal failure and liver diseases. Clinical correlation
suggested.
5. To estimate the eAG from the HbA1C value, the following equation is used: eAG(mg/dl) = 28.7*A1c-46.7
6. Interference of Haemoglobinopathies in HbA1c estimation.
            A.  For HbF > 25%, an alternate platform (Fructosamine) is recommended for testing of HbA1c.
            B.  Homozygous hemoglobinopathy is detected, fructosamine is recommended for monitoring diabetic status 
            C.  Heterozygous state detected (D10/ turbo is corrected for HbS and HbC trait).

      7.   In known diabetic patients, following values can be considered as a tool for monitoring the glycemic control. Excellent 
Control - 6 to 7 %, Fair to Good Control - 7 to 8 %, Unsatisfactory Control - 8 to 10 % and Poor Control - More than 10 % .

Note : Hemoglobin electrophoresis (HPLC method) is recommended for detecting hemoglobinopathy.

Dr. Chakshu Bansal

M.D (Pathology)
(DMC Reg. No. - 66994)

Page 2 of 10
 Mr. STEVE GARG Reference: Dr.PRABHAT ARYA VID: 230054000296258
C8/103 SRS RESIDANCY SECTOR 88 Sample Collected At: Registered On:
FARIDABAD,FARIDABAD, FARIDABAD Maa HealthCare
03/04/2023 09:28 AM
Tel No : 8700860083 SHOP NO 5960, HUDA MARKET,PART-
1,SECTOR 16A, FARIDABAD Collected On:
PIN No: 121002 HARYANA,121002 03/04/2023 9:30AM
PID NO: P542300316622 Sample Processed At: Metropolis Reported On:
Healthcare Ltd E-21, B1 Mohan Co-op Ind
Age: 25.0 Year(s) Sex: Male 03/04/2023 02:43 PM
Estate New Delhi-110044

Investigation Observed Value Unit Biological Reference Interval

ESR - Erythrocyte Sedimentation Rate 40 mm/hr <= 14
(EDTA Whole Blood)

Method: Automated, based on Westergren Method

Interpretation:

1. It indicates presence and intensity of an inflammatory process, never diagnostic of a specific disease. Changes are more
significant than a single abnormal test.
2. It is a prognostic test and used to monitor the course or response to treatment of diseases like tuberculosis, bacterial
endocarditis, acute rheumatic fever, rheumatoid arthritis, SLE, Hodgkins disease, temporal arteritis, polymyalgia rheumatica.
3. It is also increased in pregnancy, multiple myeloma, menstruation, and hypothyroidism.

Glucose fasting 102.0 mg/dL Normal: 70-99

(Fluoride Plasma-F,Hexokinase) Impaired Tolerance: 100-125
Diabetes mellitus: >= 126
(on more than one occasion)
(American diabetes association
guidelines 2021)
Liver Function Test(LFT)
SGOT (AST) 227.7 U/L 0-35
(Serum,NADH without P5P)
SGPT (ALT) 123.8 U/L 0-45
(Serum,NADH without P5P)
Alkaline Phosphatase 35 U/L 40-129
(Serum,para-Nitrophenyl-phosphate)
Gamma GT (GGTP) 40 U/L 12-64
(Serum,L-Gamma-glutamyl-3-carboxy -4 - nitroanalyte
substrate, IFCC)
BilirubinTotal, Direct, IndirectSerum
Bilirubin-Total 0.49 mg/dL 0.2-1.2
(Serum,Diazotized Sulfanilic Acid (Modified Jendrassik
& Grof))
Bilirubin-Direct 0.24 mg/dL 0.0-0.5
(Serum,Diazotized Sulfanilic Acid (Modified Jendrassik
& Grof))
Bilirubin- Indirect 0.25 mg/dL 0.1-1.0
(Serum,Calculated)
Proteins
Total Protein 6.84 g/dL 6.4-8.3
(Serum,Biuret)
Albumin 4.04 g/dL 3.5-5.2
(Serum,Bromocresol green)
Globulin 2.80 g/dL 1.8-3.6
(Serum,Calculated)

Dr. Chakshu Bansal

M.D (Pathology)
(DMC Reg. No. - 66994)
Page 3 of 10
 Mr. STEVE GARG Reference: Dr.PRABHAT ARYA VID: 230054000296258
C8/103 SRS RESIDANCY SECTOR 88 Sample Collected At: Registered On:
FARIDABAD,FARIDABAD, FARIDABAD Maa HealthCare
03/04/2023 09:28 AM
Tel No : 8700860083 SHOP NO 5960, HUDA MARKET,PART-
1,SECTOR 16A, FARIDABAD Collected On:
PIN No: 121002 HARYANA,121002 03/04/2023 9:30AM
PID NO: P542300316622 Sample Processed At: Metropolis Reported On:
Healthcare Ltd E-21, B1 Mohan Co-op Ind
Age: 25.0 Year(s) Sex: Male 03/04/2023 02:43 PM
Estate New Delhi-110044

Investigation Observed Value Unit Biological Reference Interval

A/G Ratio 1.44 1.1-2.2
(Serum,Calculated)
Renal Function Test(RFT)
Electrolytes
(Serum,Ion selective electrode, indirect)
Potassium 4.04 mEq/L 3.5-5.1
Sodium 129 mEq/L 136-145
Chlorides 91 mEq/L 98-107
BUN-Blood Urea Nitrogen 13.6 mg/dL 6-20
(Serum,Urease)
Remark:  In blood, Urea is usually reported as BUN and expressed in mg/dl. BUN mass units can be converted to urea mass units 
by multiplying by 2.14.

Creatinine 1.09 mg/dL 0.70-1.20

(Serum,Modified Jaffe)
Uric Acid 4.5 mg/dL 3.5-7.2
(Serum,Uricase)
Proteins
Total Protein 6.84 g/dL 6.4-8.3
(Serum,Biuret)
Albumin 4.04 g/dL 3.5-5.2
(Serum,Bromocresol green)
Globulin 2.80 g/dL 1.8-3.6
(Serum,Calculated)
A/G Ratio 1.44 1.1-2.2
(Serum,Calculated)
Calcium 8.43 mg/dL 8.4-10.2
(Serum,Arsenazo III dye)
Phosphorous 3.07 mg/dL 2.3-4.7
(Serum,Phospomolybdate)

Dr. Chakshu Bansal

M.D (Pathology)
(DMC Reg. No. - 66994)
Page 4 of 10
 Mr. STEVE GARG Reference: Dr.PRABHAT ARYA VID: 230054000296258
C8/103 SRS RESIDANCY SECTOR 88 Sample Collected At: Registered On:
FARIDABAD,FARIDABAD, FARIDABAD Maa HealthCare
03/04/2023 09:28 AM
Tel No : 8700860083 SHOP NO 5960, HUDA MARKET,PART-
1,SECTOR 16A, FARIDABAD Collected On:
PIN No: 121002 HARYANA,121002 03/04/2023 9:30AM
PID NO: P542300316622 Sample Processed At: Metropolis Reported On:
Healthcare Ltd E-21, B1 Mohan Co-op Ind
Age: 25.0 Year(s) Sex: Male 03/04/2023 02:43 PM
Estate New Delhi-110044

Investigation Observed Value Unit Biological Reference Interval

Lipid Profle-Mini
Cholesterol (Total) 121.6 mg/dL Desirable: < 200
(Serum,Cholesterol Oxidase- Peroxidase) Borderline High: 200-239
High: >= 240
Triglycerides level 120.9 mg/dL Normal: < 150
(Serum,Glycerol Phosphate Oxidase) Borderline High: 150-199
High: 200-499
Very High: >= 500
HDL Cholesterol 18.0 mg/dL Major risk factor for heart
(Serum,Accelerator Selective Detergent) disease: <= 40
Negative risk factor for heart
disease: >= 60
Non HDL Cholesterol 103.6 mg/dL Optimal: < 130
(Serum,Calculated) Desirable: 130-159
Borderline high: 159-189
High: 189-220
Very High: >= 220
LDL Cholesterol 79.42 mg/dL Optimal: < 100
(Serum,Calculated) Near Optimal: 100-129
Borderline high: 130-159
High: 160-189
Very High: >= 190
VLDL Cholesterol 24.18 mg/dL < 30
(Serum,Calculated)
LDL/HDL RATIO 4.41 2.5-3.5
(Serum,Calculated)
CHOL/HDL RATIO 6.76 3.5-5
(Serum,Calculated)
Note: Reference Interval as per National Cholesterol Education Program (NCEP) Adult Treatment Panel III Report.

Dr. Chakshu Bansal

M.D (Pathology)
(DMC Reg. No. - 66994)
Page 5 of 10
 Mr. STEVE GARG Reference: Dr.PRABHAT ARYA VID: 230054000296258
C8/103 SRS RESIDANCY SECTOR 88 Sample Collected At: Registered On:
FARIDABAD,FARIDABAD, FARIDABAD Maa HealthCare
03/04/2023 09:28 AM
Tel No : 8700860083 SHOP NO 5960, HUDA MARKET,PART-
1,SECTOR 16A, FARIDABAD Collected On:
PIN No: 121002 HARYANA,121002 03/04/2023 9:30AM
PID NO: P542300316622 Sample Processed At: Metropolis Reported On:
Healthcare Ltd E-21, B1 Mohan Co-op Ind
Age: 25.0 Year(s) Sex: Male 03/04/2023 02:43 PM
Estate New Delhi-110044

Investigation Observed Value Unit Biological Reference Interval

25 Hydroxy (OH) Vit D 8.18 ng/mL Deficiency: < 10
(Serum,ECLIA) Insufficiency: 10-30
Sufficiency: 30-100
Hypervitaminosis: > 100

Interpretation :

1. Vitamin D is a fat soluble vitamin and exists in two main forms as cholecalciferol(vitamin D3) which is synthesized in skin
from 7-dehydrocholesterol in response to sunlight exposure & Ergocalciferol(vitamin D2) present mainly in dietary
sources.Both cholecalciferol & Ergocalciferol are converted to 25(OH)vitamin D in liver.
2. Testing for 25(OH)vitamin D is recommended as it is the best indicator of vitamin D nutritional status as obtained from
sunlight exposure & dietary intake. For diagnosis of vitamin D deficiency it is recommended to have clinical correlation with
serum 25(OH)vitamin D, serum calcium, serum PTH & serum alkaline phosphatase.
3. During monitoring of oral vitamin D therapy- suggested testing of serum 25(OH)vitamin D is after 12 weeks or 3 mths of
treatment. However, the required dosage of vitamin D supplements & time to achieve sufficient vitamin D levels show
significant seasonal(especially winter) & individual variability depending on age, body fat, sun exposure, physical activity
,genetic factors(especially variable vitamin D receptor responses), associated liver or renal disease, malabsorption
syndromes and calcium or magnesium deficiency influencing the vitamin D metabolism Vitamin D toxicity is known but very
rare.kindly correlate clinically, repeat with fresh sample if indicated. 

Abbreviation :
ECLIA : Electrochemiluminescence Immunoassay

Associated Test Profile : 

 

• For diagnosis of vitamin D deficiency it is recommended to have clinical correlation with serum 25(OH)vitamin D and serum
PTH.An inverse relationship exists between PTH and 25(OH)D levels, Parathyroid hormone levels start to rise at 25(OH)D
levels below 31 ng/mL & usually decrease after the correction of vitamin D insufficiency.Thus, restoration of PTH and 25
(OH)D levels to normalcy after adequate vitamin D replacement therapy is a useful monitoring strategy.
• As a holistic & scientific approach for diagnosis and optimal treatment for vitamin D deficiency, Vitamin D plus profile (25
Hydroxy(OH) Vit D and PTH) is suggested.

Dr. Chakshu Bansal

M.D (Pathology)
(DMC Reg. No. - 66994)
Page 6 of 10
 Mr. STEVE GARG Reference: Dr.PRABHAT ARYA VID: 230054000296258
C8/103 SRS RESIDANCY SECTOR 88 Sample Collected At: Registered On:
FARIDABAD,FARIDABAD, FARIDABAD Maa HealthCare
03/04/2023 09:28 AM
Tel No : 8700860083 SHOP NO 5960, HUDA MARKET,PART-
1,SECTOR 16A, FARIDABAD Collected On:
PIN No: 121002 HARYANA,121002 03/04/2023 9:30AM
PID NO: P542300316622 Sample Processed At: Metropolis Reported On:
Healthcare Ltd E-21, B1 Mohan Co-op Ind
Age: 25.0 Year(s) Sex: Male 03/04/2023 02:43 PM
Estate New Delhi-110044

Investigation Observed Value Unit Biological Reference Interval

CRP - C Reactive Protein 122.01 mg/L < 5.0
(Serum,Immunoturbidimetric Assay )

Interpretation :

1. Measurement of CRP is useful for the detection and evaluation of infection, tissue injury, inflammatory disorders and
associated diseases .
2. High sensitivity CRP (hsCRP) measurements may be used as an independent risk marker for the identification of individual
at risk for future cardiovascular disease.
3. Increase in CRP values are non-Specific and should not be interpreted without a complete history.
Note :
If the test has been ordered for COVID-19 purpose, you may take one of the following profiles for further investigation under your
clinician’s advice.
1. Covid Monitor Initial profile (C0374) from Day 1 to Day 5
2. Covid Monitor maintenance profile (C0375) from Day 5 to Day 10
3. Covid Monitor Recovery profile (C0376) after discharge.

Dr. Chakshu Bansal

M.D (Pathology)
(DMC Reg. No. - 66994)
Page 7 of 10
 Mr. STEVE GARG Reference: Dr.PRABHAT ARYA VID: 230054000296258
C8/103 SRS RESIDANCY SECTOR 88 Sample Collected At: Registered On:
FARIDABAD,FARIDABAD, FARIDABAD Maa HealthCare 03/04/2023 09:28 AM
Tel No : 8700860083 SHOP NO 5960, HUDA MARKET,PART- Collected On:
PIN No: 121002 1,SECTOR 16A, FARIDABAD
03/04/2023 9:30AM
HARYANA,121002
PID NO: P542300316622 Reported On:
Sample Processed At: Metropolis
Age: 25.0 Year(s) Sex: Male Healthcare Ltd E-21, B1 Mohan Co-op 03/04/2023 02:43 PM
Ind Estate New Delhi-110044

Investigation Observed Value Unit Biological Reference Interval

Thyroid panel - 2
(Serum,ECLIA)
Free T3 2.25 pg/mL 2.0-4.4
Free T4 1.06 ng/dL 0.93-1.7
TSH(Ultrasensitive) 3.17 µIU/mL 0.54-5.3
INTERPRETATION
TSH T3 / FT3 T4 / FT4 Suggested Interpretation for the Thyroid Function Tests Pattern
Within Range Decreased Within Range • Isolated Low T3-often seen in elderly & associated Non-Thyroidal illness. In
elderly the drop in T3 level can be upto 25%.
Raised Within Range Within Range •Isolated High TSHespecially in the range of 4.7 to 15 mIU/ml is commonly
associated with Physiological & Biological TSH Variability.
•Subclinical Autoimmune Hypothyroidism
•Intermittent T4 therapy for hypothyroidism
•Recovery phase after Non-Thyroidal illness"
Raised Decreased Decreased •Chronic Autoimmune Thyroiditis
•Post thyroidectomy,Post radioiodine
•Hypothyroid phase of transient thyroiditis"
Raised or within Raised Raised or within •Interfering antibodies to thyroid hormones (anti-TPO antibodies)
Range Range •Intermittent T4 therapy or T4 overdose
•Drug interference- Amiodarone, Heparin,Beta blockers,steroids,
anti-epileptics"
Decreased Raised or within Raised or within •Isolated Low TSH -especially in the range of 0.1 to 0.4 often seen in elderly &
Range Range associated with Non-Thyroidal illness
•Subclinical Hyperthyroidism
•Thyroxine ingestion"
Decreased Decreased Decreased •Central Hypothyroidism
•Non-Thyroidal illness
•Recent treatment for Hyperthyroidism (TSH remains suppressed)"
Decreased Raised Raised •Primary Hyperthyroidism (Graves’ disease),Multinodular goitre,
Toxic nodule
•Transient thyroiditis:Postpartum, Silent (lymphocytic), Postviral
(granulomatous,subacute, DeQuervain’s),Gestational
thyrotoxicosis with hyperemesis gravidarum"
Decreased or Raised Within Range •T3 toxicosis
within Range •Non-Thyroidal illness
References:  1. Interpretation of thyroid function tests. Dayan et al. THE LANCET • Vol 357 • February 24, 2001
2. Laboratory Evaluation of Thyroid Function, Indian Thyroid Guidelines, JAPI, January 2011,vol. 59

Dr. Chakshu Bansal

M.D (Pathology)
(DMC Reg. No. - 66994)

Page 8 of 10
 Mr. STEVE GARG Reference: Dr.PRABHAT ARYA VID: 230054000296258
C8/103 SRS RESIDANCY SECTOR 88 Sample Collected At: Registered On:
FARIDABAD,FARIDABAD, FARIDABAD Maa HealthCare 03/04/2023 09:28 AM
Tel No : 8700860083 SHOP NO 5960, HUDA MARKET,PART- Collected On:
PIN No: 121002 1,SECTOR 16A, FARIDABAD
HARYANA,121002 03/04/2023 9:30AM
PID NO: P542300316622 Sample Processed At: Metropolis Reported On:
Age: 25.0 Year(s) Sex: Male Healthcare Ltd E-21, B1 Mohan Co-op 03/04/2023 02:43 PM
Ind Estate New Delhi-110044

ROUTINE EXAMINATION URINE

Investigation Observed Value Unit Biological Reference Interval
General Examination
Colour Pale Yellow Pale Yellow
Transparency (Appearance) Clear Clear
Reaction (pH) 6.0 4.5-7.0
Specific gravity 1.020 1.005-1.030
Chemical Examination
Urine Protein (Albumin) Present 1+ Absent
Urine Ketones (Acetone) Absent Absent
Urine Glucose (sugar) Absent Absent
Bile pigments Absent Absent
Bile salts Absent Absent
Urobilinogen Normal Normal
Nitrite Negative Negative
Microscopic Examination
Red blood cells Nil /hpf 0-4
Pus cells (WBCs) 2-4 /hpf 0-9
Epithelial cells 1-2 /hpf 0-4
Crystals Absent Absent
Cast Absent Absent
Bacteria Absent Absent
Trichomonas Vaginalis Absent Absent
Yeast cells Absent Absent
Note : 1. Chemical examination through Dipstick includes test methods as Protein (Protein Error Principle), Glucose (Glucose
oxidase-Peroxidase), Ketone (Legals Test), Bilirubin (Azo- Diazo reaction),Urobilinogen (Diazonium ion Reaction) Nitrite (Griess
Method). Abnormal results of chemical examination are confirmed by manual methods. 2. Pre-test conditions to be observed
while collecting the sample- First void, mid-stream urine, collected in a clean, dry, sterile container is recommended to avoid 
contamination with any discharge vaginal, urethral, perineal as applicable. Avoid prolonged transit time & undue exposure to
sunlight. 3. During interpretation, points to be considered are Negative nitrite test does not exclude the urinary tract infections, Trace
proteinuria can be seen with many physiological conditions like prolonged recumbency, exercise, high protein diet. False positive
reactions for bile pigments, proteins, glucose and nitrites can be caused by peroxidase like activity by disinfectants, therapeutic
dyes, ascorbic acid and certain drugs.4.All samples are checked for adequacy and suitability before examination.

-- End of Report --

Dr. Chakshu Bansal

M.D (Pathology)
(DMC Reg. No. - 66994)
Page 9 of 10
Mr. STEVE GARG Reference: Dr.PRABHAT ARYA VID: 230054000296258
C8/103 SRS RESIDANCY SECTOR 88 Sample Collected At: Registered On:
FARIDABAD,FARIDABAD, FARIDABAD Maa HealthCare 03/04/2023 09:28 AM
Tel No : 8700860083 SHOP NO 5960, HUDA MARKET,PART- Collected On:
PIN No: 121002 1,SECTOR 16A, FARIDABAD
HARYANA,121002 03/04/2023 9:30AM
PID NO: P542300316622 Sample Processed At: Metropolis Reported On:
Age: 25.0 Year(s) Sex: Male Healthcare Ltd E-21, B1 Mohan Co-op 03/04/2023 02:43 PM
Ind Estate New Delhi-110044

Tests marked with NABL symbol are accredited by NABL vide Certificate no MC-2676; Validity till 04-04-2024

Page 10 of 10
Dr. Chakshu Bansal
M.D (Pathology)
(DMC Reg. No. - 66994)